International Chemical Investors Group is buying Peptisyntha SA.

Peptisyntha, headquartered in Brussels, Belgium, manufactures peptides for pharmaceutical use. The peptides are manufactured by linking amino acids together. Terms of the deal were not disclosed.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.